“These suggestions can help clinics and providers make changes to how they communicate screening mammogram results,” wrote Biren A. Shah, MD, of Virginia Commonwealth University Health System in Richmond, in a recent Journal of the American College of Radiology study.

For AI to become clinically feasible in women’s imaging, it must excel in the areas of performance, time, workflow and cost, according to an opinion piece published online Feb. 19 in the American Journal of Roentgenology.  

The Department of Energy’s Nuclear Security Administration (NNSA) has chosen four U.S. companies to begin negotiations with in an effort to produce Molybdenum-99 (Mo-99) without the use of highly enriched uranium.

A novel PET/CT imaging agent—18F-GP1—produced a high quality image and yielded a high detection rate for diagnosing acute venous thromboembolism (VTE), reported researchers of a study featured in the February issue of The Journal of Nuclear Medicine.

Stereotactic ablative body radiation therapy (SABR) nearly doubled the overall survival of patients with inoperable stage I lung cancer compared to standard radiotherapy, according to results of a multi-center phase III trial published in Lancet Oncology.

The FDA has approved nerve stimulation for treatment of episodic and chronic cluster headaches and acute migraines. The findings, detailed in a study published online Feb. 13 in PLOS ONE, could help personalize treatment for PTSD, which according to the National Institute of Mental Health impacts roughly 3.6 percent of U.S. adults per year. 

Autosomal dominant polycystic kidney disease (ADPKD) is among the most common hereditary diseases and is associated with complications such as intracranial aneurysm. A lack of screening guidelines prompted a group of researchers to evaluate the cost-effectiveness of various MR angiography strategies.